CVE-2012-6682: Cross-site scripting (XSS) vulnerability in downloads/actions/editdownload.php in the DragonByte Technologies
CVE-2012-6682 is a medium-severity flaw (CVSS 6.1) affecting vbdownloads module. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
Cross-site scripting (XSS) vulnerability in downloads/actions/editdownload.php in the DragonByte Technologies vBDownloads module 1.3.2 and earlier for vBulletin allows remote attackers to inject arbitrary web script or HTML via the mirrors[] parameter.
Why this priority
- No elevated risk signals yet
No fix is published yet: follow the downgrade or mitigation steps.
Risk facts
| CVSS score | 6.1 (Medium) |
| Attack vector | Network (remote) |
| Attack complexity | Low |
| Privileges needed | None |
| User interaction | Required |
| EPSS exploit chance | 1.7% (top 23%) |
| CISA exploited list | No |
| Weakness | CWE-79 |
| Published | 2018-01-11 |
| Last modified | 2026-06-16 |
Last updated 2026-06-16 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Am I affected?
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2012-6682?
vbdownloads module: downgrade or apply the listed mitigation. Exact commands for each OS are on this page.
Is CVE-2012-6682 being exploited?
CVE-2012-6682 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2012-6682 affect?
CVE-2012-6682 affects vbdownloads module. Severity is medium (CVSS 6.1). Cross-site scripting (XSS) vulnerability in downloads/actions/editdownload.php in the DragonByte Technologies vBDownloads module 1.3.2 and earlier for vBulletin allows remote attackers to inject arbitrary web script or HTML via the mirrors[
How urgent is CVE-2012-6682?
Priority 41/100. No elevated risk signals yet.